Nelson Peltz is joining Canadian medical cannabis firm Aurora as a major shareholder and Strategic Advisor, according to a report published by Bloomberg. Peltz has been granted 20 million options to purchase Aurora stock at US$10.34 per share. If exercised in full, he would become the second-largest shareholder in the firm.
“Nelson comes with a phenomenal track record and was very excited about the growth opportunity here at Aurora,” Chairman Michael Singer told Bloomberg during a phone interview. “He isn’t as antagonistic as some of the market may portray him to be and he collaborates closely with the company’s board and management, and we thought that recipe and his deep connection to global business that we think are going to be value-added to our business going forward was the right recipe.”
“I believe Aurora has a solid execution track record, is strongly differentiated from its peers, has achieved integration throughout the value chain and is poised to go to the next level,” said Peltz in a statement, per Bloomberg.